-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25

Benzinga·05/12/2026 21:57:16
Listen to the news
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $22 to $25.